Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Rating) had its target price boosted by research analysts at HC Wainwright from $350.00 to $400.00 in a report issued on Tuesday, The Fly reports. HC Wainwright’s target price suggests a potential upside of 154.08% from the stock’s current price. Several other equities analysts also recently weighed in on ALNY. […]